Skip to content

MB-CART19.1 in refractory SLE

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507654-33-00
Acronym
M-2022-398
Enrollment
30
Registered
2023-10-23
Start date
2024-08-12
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory systemic lupus erythematosus (SLE)

Interventions

None listed

Sponsors

Miltenyi Biomedicine GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026